--The Japanese government is in talks to procure Merck & Co.'s potential Covid-19 drug as soon as the end of the year, Japanese business daily Nikkei reported Sunday without citing sources.
--If the drug is approved in the U.S. and an application is made in Japan, the country's health ministry would consider approving the drug through an expedited process, the Nikkei report said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.